Skip to main content
IDXG logo

IDXG · Interpace Biosciences, Inc. · Debt

Track IDXG — free
$3.25 At close · Feb 25
Market Cap
$42.19M
Shares
5.54M
Volume · Feb 25 186.4K Avg daily vol (3M) —

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Operating lease liabilities 2026-06-30 USD 974,000 10-Q filed 2026-08-10
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current operating lease liabilities
USD 458,000
Noncurrent operating lease liabilities
USD 516,000
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Key facts CIK 1054102 CUSIP 46062X303 Visit website Investor relations